This inventor holds 1 USPTO granted patent. Top assignee: Catalyst Therapeutics Pty Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovations of Phillip Patrick Sharp
Introduction
Phillip Patrick Sharp is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic potential. His work focuses on creating innovative solutions that address critical health challenges.
Latest Patents
One of Phillip Patrick Sharp's key patents is titled "Benzodiazepines as bromodomain inhibitors." This invention provides novel benzodiazepine derivatives of Formula I or pharmaceutically acceptable derivatives, polymorphs, salts, or prodrugs thereof. These compounds have potential as bromodomain (BRD) inhibitors, showcasing his commitment to advancing medical science.
Career Highlights
Phillip Patrick Sharp is associated with Catalyst Therapeutics Pty Ltd., where he continues to push the boundaries of pharmaceutical research. His work has led to the development of innovative therapeutic agents that may significantly impact patient care.
Collaborations
Throughout his career, Phillip has collaborated with esteemed colleagues such as Jean-Marc Garnier and John Feutrill. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Phillip Patrick Sharp's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in medical research and therapeutic development.